NCT07212946View on ClinicalTrials.gov

Ayahuasca and Esketamine for Major Depression

PHASE2CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

October 30, 2022

Primary Completion Date

October 30, 2024

Study Completion Date

October 1, 2025

Conditions

Major Depression Severe

Interventions

DRUG

Ayahuasca

Ayahuasca (oral)

DRUG

Esketamine

oral esketamine (2 mg/kg)

Trial Locations (1)

14049900

Hospital das Clínicas da FMRP-USP, Ribeirão Preto

All Listed Sponsors

lead

University of Sao Paulo

OTHER